Christopher D. Willey

Small-RNA Profiling Links 5'-tRNA Halves to Post-therapeutic Disease Persistence and Poor Patient Survival in Glioblastoma.

Journal: bioRxiv : the preprint server for biology

Published: July 29, 2026

Randomized, double-blind, sham-controlled trial of an intraoral photobiomodulation device for oral mucositis and associated complications due to radiotherapy for head and neck cancer.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: April 13, 2026

Development and characterization of [47Sc]Sc-NOTA-trastuzumab for targeted radiotherapy in primary and metastatic HER2 + breast cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 02, 2026

MARCKS as a mediator and target for pathological tunneling nanotubes between patient-derived glioblastoma cells and astrocytes.

Journal: Cell death & disease

Published: February 17, 2026

Induro-seq to analyze subcellular enrichment of small RNAs.

Journal: Methods in enzymology

Published: December 03, 2025

Long-Term Outcomes of Advanced Pneumatic Compression Device vs. Usual Care Therapy for Head and Neck Cancer-Related Lymphedema: A Multi-Site Randomized Clinical Trial.

Journal: International journal of radiation oncology, biology, physics

Published: November 28, 2025

Impact of Distance From the Isocenter on Local Control and Toxicity for Zero Margin, Single-Isocenter Multitarget Volumetric Modulated Arc Therapy-Based Stereotactic Radiosurgery for Brain Metastases.

Journal: International journal of radiation oncology, biology, physics

Published: November 25, 2025

CD8 immunoPET imaging to stratify response and guide combination immunotherapy and radiation in triple negative breast cancer.

Journal: Breast cancer research : BCR

Published: November 13, 2025

AI-based framework to fuse pre-RT brain metastases contours with follow-up MRI to improve post-RT assessment.

Journal: Neuro-oncology practice

Published: September 12, 2025

A Novel Serum-Free Triculture Model of Glioblastoma, Astrocytes, and Macrophages.

Journal: International journal of molecular sciences

Published: August 12, 2025

Frameless linac-based radiosurgery for benign intracranial tumors treated with HyperArc: analysis of tumor control and toxicity.

Journal: Journal of neuro-oncology

Published: August 01, 2025

Short-Term Outcomes of Advanced Pneumatic Compression Device Versus Usual Care Therapy for Head and Neck Cancer-Related Lymphedema: A Multi-Site Randomized Clinical Trial.

Journal: Head & neck

Published: July 27, 2025

Small-RNA Profiling Links 5'-tRNA Halves to Post-therapeutic Disease Persistence and Poor Patient Survival in Glioblastoma.

Small-RNA Profiling Links 5'-tRNA Halves to Post-therapeutic Disease Persistence and Poor Patient Survival in Glioblastoma.

Randomized, double-blind, sham-controlled trial of an intraoral photobiomodulation device for oral mucositis and associated complications due to radiotherapy for head and neck cancer.

Randomized, double-blind, sham-controlled trial of an intraoral photobiomodulation device for oral mucositis and associated complications due to radiotherapy for head and neck cancer.

Development and characterization of [47Sc]Sc-NOTA-trastuzumab for targeted radiotherapy in primary and metastatic HER2 + breast cancer.

Development and characterization of [47Sc]Sc-NOTA-trastuzumab for targeted radiotherapy in primary and metastatic HER2 + breast cancer.

MARCKS as a mediator and target for pathological tunneling nanotubes between patient-derived glioblastoma cells and astrocytes.

MARCKS as a mediator and target for pathological tunneling nanotubes between patient-derived glioblastoma cells and astrocytes.

Induro-seq to analyze subcellular enrichment of small RNAs.

Induro-seq to analyze subcellular enrichment of small RNAs.

Long-Term Outcomes of Advanced Pneumatic Compression Device vs. Usual Care Therapy for Head and Neck Cancer-Related Lymphedema: A Multi-Site Randomized Clinical Trial.

Long-Term Outcomes of Advanced Pneumatic Compression Device vs. Usual Care Therapy for Head and Neck Cancer-Related Lymphedema: A Multi-Site Randomized Clinical Trial.

Impact of Distance From the Isocenter on Local Control and Toxicity for Zero Margin, Single-Isocenter Multitarget Volumetric Modulated Arc Therapy-Based Stereotactic Radiosurgery for Brain Metastases.

Impact of Distance From the Isocenter on Local Control and Toxicity for Zero Margin, Single-Isocenter Multitarget Volumetric Modulated Arc Therapy-Based Stereotactic Radiosurgery for Brain Metastases.

CD8 immunoPET imaging to stratify response and guide combination immunotherapy and radiation in triple negative breast cancer.

CD8 immunoPET imaging to stratify response and guide combination immunotherapy and radiation in triple negative breast cancer.

AI-based framework to fuse pre-RT brain metastases contours with follow-up MRI to improve post-RT assessment.

AI-based framework to fuse pre-RT brain metastases contours with follow-up MRI to improve post-RT assessment.

A Novel Serum-Free Triculture Model of Glioblastoma, Astrocytes, and Macrophages.

A Novel Serum-Free Triculture Model of Glioblastoma, Astrocytes, and Macrophages.

Frameless linac-based radiosurgery for benign intracranial tumors treated with HyperArc: analysis of tumor control and toxicity.

Frameless linac-based radiosurgery for benign intracranial tumors treated with HyperArc: analysis of tumor control and toxicity.

Short-Term Outcomes of Advanced Pneumatic Compression Device Versus Usual Care Therapy for Head and Neck Cancer-Related Lymphedema: A Multi-Site Randomized Clinical Trial.

Short-Term Outcomes of Advanced Pneumatic Compression Device Versus Usual Care Therapy for Head and Neck Cancer-Related Lymphedema: A Multi-Site Randomized Clinical Trial.

Development and characterization of [47Sc]Sc-NOTA-trastuzumab for targeted radiotherapy in primary and metastatic HER2 + breast cancer.

Development and characterization of [47Sc]Sc-NOTA-trastuzumab for targeted radiotherapy in primary and metastatic HER2 + breast cancer.